Equisetum arvense, ext.(CAS: 71011-23-9)

Equisetum arvense extract (CAS: 71011-23-9) must comply with the REACH regulations in the EU, ensuring the safety of the substance. Additionally, it should adhere to FDA guidelines for dietary supplements and EPA regulations for environmental discharge. GHS classification is also required to identify potential hazards and provide safety data sheets (SDS) to users and handlers.

There are alternative botanical extracts that can be used as substitutes for Equisetum arvense extract (CAS: 71011-23-9) in synthesis, such as horsetail extract or other silica-rich botanicals. These alternatives can offer similar benefits, including antioxidant and anti-inflammatory properties, but may require optimization in the synthesis process.

The market for Equisetum arvense extract (CAS: 71011-23-9) is growing due to increasing interest in natural ingredients for health and wellness products. Research trends are focusing on its potential therapeutic applications, such as anti-aging and anti-inflammatory effects. However, there is a need for more extensive clinical studies to confirm these benefits.

Waste containing Equisetum arvense extract (CAS: 71011-23-9) should be collected in sealed containers and disposed of according to local hazardous waste regulations. Incineration is a common method for disposal, but ensure that it complies with environmental protection standards. It is also advisable to consult with a waste management professional to ensure proper handling and disposal to prevent environmental contamination.